Gsk (GSK) Non-Current Assets (2009 - 2026)
Gsk (GSK) posted Non-Current Assets of $59.27 billion for the quarter ended Jun 30, 2026, up 6.8% from $55.48 billion a year earlier but down 2.5% from the prior quarter.
Powered by 
Analysis
Gsk (GSK) Non-Current Assets (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Gsk's Non-Current Assets came in at $57.5 billion, up 5.9% from the prior year.
- Annual Non-Current Assets has increased for three consecutive years, though with a five-year compound annual growth rate of -5.7% (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Non-Current Assets was $54.28 billion in the year ended Dec 31, 2024 (+8.1%), $50.2 billion in the year ended Dec 31, 2023 (+3.0%), $48.73 billion in the year ended Dec 31, 2022 (-41.4%) and $83.14 billion in the year ended Dec 31, 2021 (+7.6%).
- Quarterly Non-Current Assets has run from a low of $39.89 billion in the quarter ended Mar 31, 2022 to a high of $83.31 billion in the quarter ended Sep 30, 2021 over five years.
- On a year-over-year basis, Non-Current Assets has increased in each of the last 14 quarters, with growth averaging 7.6% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was the quarter ended Mar 31, 2023, with growth of 18.5%; the weakest was the quarter ended Mar 31, 2022, with a decline of 51.4%.
- According to Business Quant data, Non-Current Assets for the three prior quarters was $60.81 billion (quarter ended Mar 31, 2026), $58.01 billion (quarter ended Dec 31, 2025) and $58.69 billion (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | 59.27 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.27 Bn |
| Mar 31, 2026 | 60.81 Bn |
| Dec 31, 2025 | 58.01 Bn |
| Sep 30, 2025 | 58.69 Bn |
| Jun 30, 2025 | 55.48 Bn |
| Mar 31, 2025 | 53.68 Bn |
| Dec 31, 2024 | 54.51 Bn |
| Sep 30, 2024 | 52.95 Bn |
| Jun 30, 2024 | 52.13 Bn |
| Mar 31, 2024 | 52.40 Bn |
| Dec 31, 2023 | 50.09 Bn |
| Sep 30, 2023 | 50.19 Bn |
| Jun 30, 2023 | 50.20 Bn |
| Mar 31, 2023 | 47.26 Bn |
| Dec 31, 2022 | 46.19 Bn |
| Sep 30, 2022 | 47.22 Bn |
| Jun 30, 2022 | 43.90 Bn |
| Mar 31, 2022 | 39.89 Bn |
| Dec 31, 2021 | 81.46 Bn |
| Sep 30, 2021 | 83.31 Bn |
API Access
Gsk Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();